You are here

Eli Lilly

Lilly doubles down on Dexcom tech for connected insulin devices

Pharmaforum

Tue, 12/17/19 - 10:24 am

continuous glucose monitoring

Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint

Pharmaceutical Business Review

Mon, 12/16/19 - 10:35 am

Boehringer Ingelheim

type 2 diabetes

chronic heart failure

clinical trials

Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga

Fierce Pharma

Fri, 12/13/19 - 09:05 pm

Boehringer Ingelheim

Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer

EP Vantage

Fri, 12/13/19 - 11:02 am

Axsome Therapeutics

treatment-resistant depression

Leukemia rivals try to stay ahead as Merck, Lilly chase

Biopharma Dive

Tue, 12/10/19 - 11:53 pm

ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data

Fierce Biotech

Sun, 12/8/19 - 10:20 pm

Lilly puts its cancer future in Loxo's hands

Biopharma Dive

Thu, 12/5/19 - 10:20 am

Lilly putting $400M into U.S. diabetes production, adding 100 jobs

Fierce Pharma

Wed, 11/20/19 - 10:24 am

drug manufacturing

AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds

Fierce Pharma

Mon, 11/18/19 - 10:29 am

Boehringer Ingelheim

clinical trials

FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes

Zacks.com

Thu, 11/14/19 - 10:25 am

Boehringer Ingelheim

type 1 diabetes

Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy

Endpoints

Wed, 11/13/19 - 10:09 am

myotonic muscular dystrophy

Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure

Pharmaceutical Business Review

Wed, 11/13/19 - 10:02 am

Boehringer Ingelheim

Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data

Fierce Pharma

Tue, 11/12/19 - 09:51 am

psoriatic arthritis

Lilly and Boehringer rejig diabetes alliance as Jardiance soars

Pharmaforum

Tue, 11/5/19 - 10:21 am

Boehringer Ingelheim

type 2 diabetes

Dogs help Eli Lilly scientists identify new osteoarthritis target

Fierce Biotech

Fri, 11/1/19 - 10:25 am

osteoarthritis in dogs

Lilly counts on growing markets to boost lagging Taltz, Trulicity

Fierce Pharma

Thu, 10/24/19 - 10:55 am

type 2 diabetes

Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data

Bloomberg

Wed, 10/23/19 - 10:29 pm

Alzheimer's disease

Lilly USA diabetes chief Enrique Conterno bows out after 27 years

Fierce Pharma

Wed, 10/23/19 - 03:00 pm

Enrique Conterno

Eli Lilly (LLY) Surpasses Q3 Earnings Estimates

Yahoo/Zacks.com

Wed, 10/23/19 - 09:31 am

The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict

Yahoo/Benzinga

Sun, 10/20/19 - 05:18 pm

Gilead Sciences

Edwards Lifesciences

Baxter International

Integra LifeSciences

Phathom Pharmaceuticals

Eton Pharmaceuticals

Melinta Therapeutics

Ligand Pharmaceuticals

Pages